Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 7 Lymphatic Metastasis 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 3 Breast Neoplasms 3 Thyroid Cancer, Papillary 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Postoperative Complications 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lymphedema 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Clinical Stage I Gastric Cancer AJCC v8 2 Carcinoma, Transitional Cell 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Urologic Neoplasms 1 Ureteral Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Recurrence 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Platelet Glycoprotein IV Deficiency 1 Parotid Neoplasms 1

Interventions

Gemcitabine 13 pembrolizumab 9 Specimen Handling 9 enfortumab vedotin 8 Cisplatin 8 Magnetic Resonance Spectroscopy 7 avelumab 5 Carboplatin 5 vinflunine 4 Nivolumab 4 atezolizumab 3 Immunoglobulin G 3 Disulfides 3 Biopsy 3 eribulin 2 cabozantinib 2 Standard of Care 2 Ramucirumab 2 Radiotherapy 2 Platinum 2 Nephroureterectomy 2 Ipilimumab 2 Doxorubicin 2 Docetaxel 2 CTLA-4 Antigen 2 Bortezomib 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tremelimumab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ureteral Neoplasms × Lymph Node Excision × Clear all

NCT02607709 2024-01-30

Lymphadenectomy in Urothelial Carcinoma

Zealand University Hospital

Phase NA Suspended

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡